NEW YORK - Japanese researchers have reportedly found a tie between chronic hepatitis B (HBV) and carotid atherosclerosis.
The team's report, published in the Journal of the American Heart Association, details the population-based study. Studying 4,686 men and women aged 22-88, researchers examined a variety of health statistics provided via each patient's general health screening. Patients were examined between August 1994 and May 2001.
Of those studied, 1,294 had carotid artery plaque and 40 were positive for hepatitis B.
The report determined that the link was made within this test group, but further research should continue in countries that have a higher prevalence of hepatitis B infection.
Information from www.givenimaging.com
Health at Risk: The Impact of Antimicrobial Resistance From a Global to Local Health Perspective
March 6th 2024Discover the critical role infection preventionists play in combating multidrug-resistant organisms, from the impact on patient care to the challenges of treatment, and the evolving landscape of antimicrobial resistance with Katharine J Hoffman, MPH, CIC.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
FDA Approves Enmetazobactam for Complicated UTIs: A Breakthrough in Antimicrobial Therapy
February 26th 2024Enmetazobactam (Exblifep; Orchid Pharma) has received FDA approval for treating complicated urinary tract infections (cUTIs), offering a promising solution in the battle against antimicrobial resistance.